Insulet Executive and Leadership Team

Ashley McEvoy, the Director, President & Chief Executive Officer at Insulet, directs the overarching corporate strategy and global expansion of the Omnipod platform. Overseeing the transition of medical device technology into broader therapeutic applications, the Director, President & Chief Executive Officer ensures alignment between product innovation and market demand. This leadership role involves managing complex stakeholder relationships and driving long-term value for shareholders. By prioritizing the simplification of insulin delivery, Ashley McEvoy directly impacts the lives of patients across North American and international markets. The Director, President & Chief Executive Officer maintains a focus on operational excellence, ensuring that the organization remains at the forefront of the medical device industry. Through rigorous oversight of corporate initiatives, the Director, President & Chief Executive Officer secures the company's position as a leader in wearable health technology, fostering a culture of continuous improvement and patient-centric development.

Carsten Boess, the Chief Financial Officer at Insulet, manages the fiscal health and capital allocation strategies necessary to support the growth of the Omnipod product line. Overseeing financial planning, reporting, and investor relations, the Chief Financial Officer ensures the company maintains the liquidity required for research and development. This leadership role involves analyzing market trends to optimize resource distribution across global operations. By implementing robust financial controls, Carsten Boess directly supports the scalability of the manufacturing processes that define the company's market presence. The Chief Financial Officer collaborates with the executive team to evaluate investment opportunities in new therapeutic areas, ensuring that financial objectives align with the broader mission of improving patient care. Through disciplined fiscal management, the Chief Financial Officer provides the stability needed to navigate the competitive landscape of the medical device sector, ultimately driving sustainable growth and long-term profitability for the organization.

Timothy Stonesifer, the Chief Financial Officer, At Alcon Inc at Insulet, provides strategic financial oversight to ensure the company maintains a competitive edge in the medical device market. Overseeing capital structure and risk management, the Chief Financial Officer, At Alcon Inc ensures that the organization effectively manages its financial resources to support ongoing innovation. This leadership role involves evaluating the economic impact of new product launches and market expansions. By monitoring financial performance metrics, Timothy Stonesifer directly contributes to the company's ability to sustain its growth trajectory. The Chief Financial Officer, At Alcon Inc works with the board to ensure transparency and accountability in all financial reporting. Through rigorous analysis of market conditions, the Chief Financial Officer, At Alcon Inc helps the company navigate the complexities of the global healthcare economy, ensuring that the business remains well-positioned to deliver value to patients and stakeholders through its unique insulin delivery solutions.

Ana Chadwick, the Executive Vice President & Chief Financial Officer & Treasurer at Insulet, manages the treasury functions and financial strategy that underpin the company's operational scale. Overseeing cash management, debt financing, and investment strategies, the Executive Vice President & Chief Financial Officer & Treasurer ensures the company maintains the financial flexibility to pursue its mission. This leadership role involves coordinating with global financial institutions to support the company's international presence. By optimizing the balance sheet, Ana Chadwick directly enables the funding of research and development for the Omnipod platform. The Executive Vice President & Chief Financial Officer & Treasurer collaborates with the executive team to assess the financial viability of new market entries and product lines. Through disciplined treasury management, the Executive Vice President & Chief Financial Officer & Treasurer provides the necessary financial foundation for the company to continue its work in improving the lives of people with diabetes and other conditions.

Nikkole DeMars, the Director, E2E CX Planning and Operations (Chief of Staff To GVP of E2E CX) at Insulet, architects the end-to-end customer experience strategy to ensure seamless interaction with the Omnipod system. Overseeing operational workflows and cross-functional planning, the Director, E2E CX Planning and Operations (Chief of Staff To GVP of E2E CX) ensures that patient support services remain efficient and accessible. This leadership role involves coordinating internal teams to streamline the delivery of medical devices to users across diverse geographic regions. By optimizing the customer journey, Nikkole DeMars directly enhances user satisfaction and product adoption rates. The Director, E2E CX Planning and Operations (Chief of Staff To GVP of E2E CX) facilitates communication between departments to resolve operational bottlenecks, ensuring that the company's service model evolves alongside its technological advancements. Through meticulous planning and execution, the Director, E2E CX Planning and Operations (Chief of Staff To GVP of E2E CX) strengthens the company's reputation for reliability and patient-focused care.

Lisa Davis, the Chief Human Resources Officer & Senior Vice President at Insulet, directs the talent acquisition and organizational development strategies that fuel the company's innovation. Overseeing the cultivation of a high-performance culture, the Chief Human Resources Officer & Senior Vice President ensures that the workforce possesses the technical expertise required to advance the Omnipod platform. This leadership role involves designing compensation structures and professional development programs that attract top-tier talent in the medical device industry. By fostering an inclusive and collaborative environment, Lisa Davis directly supports the company's ability to execute complex engineering and manufacturing projects. The Chief Human Resources Officer & Senior Vice President works closely with the executive team to align human capital initiatives with the company's long-term growth objectives. Through strategic workforce planning, the Chief Human Resources Officer & Senior Vice President ensures that the organization remains agile and capable of meeting the evolving needs of patients globally.

Rakesh Pant, the Staff Software Engineer & Chief Technology Officer, Cloud Data Products at Insulet, architects the cloud infrastructure that powers the digital components of the Omnipod system. Overseeing the development of data-driven products, the Staff Software Engineer & Chief Technology Officer, Cloud Data Products ensures that patient data remains secure and actionable. This leadership role involves integrating software solutions with wearable hardware to provide real-time insights for diabetes management. By leveraging cloud technology, Rakesh Pant directly improves the connectivity and functionality of the company's medical devices. The Staff Software Engineer & Chief Technology Officer, Cloud Data Products collaborates with engineering teams to scale digital platforms that support the company's expansion into new therapeutic areas. Through the implementation of advanced software architectures, the Staff Software Engineer & Chief Technology Officer, Cloud Data Products drives the digital transformation of the company's product portfolio, ensuring that users benefit from the latest advancements in health-tech connectivity and data analytics.

Trang Ly, the Senior Vice President, Chief Medical Officer at Insulet, directs the clinical research and medical strategy that validate the efficacy of the Omnipod system. Overseeing clinical trials and regulatory interactions, the Senior Vice President, Chief Medical Officer ensures that all products meet the highest standards of safety and performance. This leadership role involves translating complex medical data into actionable insights for product development teams. By leading the medical affairs department, Trang Ly directly influences the company's approach to patient care and therapeutic innovation. The Senior Vice President, Chief Medical Officer collaborates with healthcare providers to ensure that the company's technology addresses the real-world needs of patients. Through rigorous clinical oversight, the Senior Vice President, Chief Medical Officer secures the necessary evidence to support the expansion of the company's drug delivery platform into new therapeutic areas, ensuring that all medical advancements remain grounded in scientific excellence and patient safety.